MediLumine’s Mvivo Au contrast agent was injected at a dose of 0.1 ml in nude mice grafted with Sdhb(-/-) and scanned with Mediso nanoScan PET/CT at Inserm U970, Paris, France (Viel T, Yoganathan T, Perez-Liva M, Tavitian B). 3D CT images of tumor vasculature were generated with Amira 3D visualization and analysis software for life sciences (Thermo Fisher Scientific).
MediLumine is honored to be named a finalist for the 2025 World Molecular Imaging Congress (WMIC) Commercial Innovation of the Year Award. The nomination recognizes
Vascular structure of the tumour. Three-dimensional rendering of the vascular structure of the LM8 osteosarcoma tumour as visualized in μCT after staining with Vascupaint. Background:
